Michael Gelband’s ANI Pharmaceuticals ANIP Stock Holding History

Michael Gelband’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72M	Buy	+32,838	New	+$2.63M	0.02%	702
2026 Q1	–	Sell	-3,078	Closed	-$243K	–	1533
2025 Q4	$243K	Buy	+3,078	New	+$267K	﹤0.01%	1357
2025 Q3	–	Sell	-19,654	Closed	-$1.28M	–	1508
2025 Q2	$1.28M	Sell	19,654 -34,345	-64%	-$2.24M	0.01%	885
2025 Q1	$3.62M	Buy	+53,999	New	+$3.23M	0.04%	516
2021 Q4	–	Sell	-6,345	Closed	-$208K	–	2138
2021 Q3	$208K	Buy	+6,345	New	+$197K	﹤0.01%	1766
2020 Q3	–	Sell	-6,419	Closed	-$208K	–	1719
2020 Q2	$208K	Buy	+6,419	New	+$230K	0.01%	1497

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's ANIP Position: Q2 2026 in Review

Michael Gelband opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 32,838 shares worth $2.72M. The stake represents 0.02% of the portfolio and ranks #702 among its holdings. This is a return to the name: Michael Gelband previously reported a position in ANIP as recently as Q4 2025.

Michael Gelband first reported a position in ANIP in Q2 2020 and has held it in 6 quarters since. The position peaked at $3.62M in Q1 2025. 305 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Michael Gelband held 32,838 shares of ANI Pharmaceuticals worth $2.72M as of Q2 2026.
ANI Pharmaceuticals was a new Michael Gelband position in Q2 2026.
ANI Pharmaceuticals made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #702 holding.
Michael Gelband first reported a position in ANI Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
Michael Gelband's ANI Pharmaceuticals position peaked at $3.62M in Q1 2025.
305 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.